Finance

Lists
Why is TLSI up 6.67%?
Dive Deeper
TLSI:NASDAQ
TriSalus Life Sciences Inc
$2.32
+6.67%
(+0.14) 1D
$2.32
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TLSI...
Open
$2.19
High
$2.37
Low
$2.19
Mkt. cap
143.47M
Avg. vol.
275.30K
Volume
539.26K
52-wk high
$7.95
52-wk low
$2.16
EPS
-$0.49
Beta
0.50
Shares outstanding
61.70M
No. of employees
102
Open
$2.19
High
$2.37
Low
$2.19
Mkt. cap
143.47M
Avg. vol.
275.30K
Volume
539.26K
52-wk high
$7.95
52-wk low
$2.16
EPS
-$0.49
Beta
0.50
Shares outstanding
61.70M
No. of employees
102
News stories
From web sources and news partners
About TriSalus Life Sciences Inc
CEO-
Employees102
Founded2009
HeadquartersWestminster, Colorado, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to TLSI in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TLSI in the last 3 months.
Highest
Current $2.32
$10.00 (+331.03%)
Average
$6.25 (+169.40%)
Lowest
$4.00 (+72.41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Justin Walsh
JonesTrading
Buy
Reiterated
$5.00
+115.5%
11/16/2026
Frank Takkinen
Lake Street
Buy
Maintained
$6.00
+158.6%
11/11/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
$4.00
+72.4%
11/11/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$10.00
+331%
11/11/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$14.00
+503.4%
08/10/2026
Carl Byrnes
Northland Securities
Buy
Reiterated
$8.00
+244.8%
03/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
13.20M
8.90M
11.41M
12.88M
Cost of goods sold
1.76M
1.23M
1.51M
1.78M
Cost of revenue
1.76M
1.23M
1.51M
1.78M
Research and development expenses
2.57M
3.22M
3.14M
3.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.14M
12.86M
16.58M
15.61M
Operating expense
14.71M
16.08M
19.71M
18.80M
Total operating expenses
16.48M
17.31M
21.22M
20.59M
Operating income
-3.27M
-8.41M
-9.81M
-7.71M
Other non operating income
-60.00K
3.82M
2.66M
-703.00K
EBT including unusual items
-9.75M
1.54M
-9.18M
-8.85M
EBT excluding unusual items
-4.61M
-5.86M
-8.19M
-9.59M
Income tax expense
-
4.00K
4.00K
4.00K
Effective tax rate
-
0.26%
-0.04%
-0.05%
Other operating expenses
-
-
-
-
Net income
-9.75M
1.54M
-9.19M
-8.85M
Net profit margin
-73.86%
17.29%
-80.54%
-68.75%
Earnings per share
-0.05
-0.14
-
-
Interest and investment income
177.00K
164.00K
457.00K
382.00K
Interest expense
-1.45M
-1.44M
-1.49M
-1.56M
Net interest expenses
-1.28M
-1.27M
-1.03M
-1.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.14M
-8.28M
-9.68M
-7.58M
Gain or loss from assets sale
3.00K
1.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps